Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.37 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.37 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.37 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.37 |
| ▸ | PYGB | P11216 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24205780 | 1.00 | MAPK1 (0.47) | MAPK1ALDH1A1THRBLGALS1LGALS3 | |
| SCHEMBL6037671 | 1.00 | MAPK1 (0.47) | MAPK1ALDH1A1THRBLGALS1LGALS3 | |
| SCHEMBL730123 | 1.00 | MAPK1 (0.47) | MAPK1ALDH1A1THRBLGALS1LGALS3 | |
| SCHEMBL7687547 | 1.00 | MAPK1 (0.47) | MAPK1ALDH1A1THRBLGALS1LGALS3 | |
| SCHEMBL7085221 | 1.00 | MAPK1 (0.47) | MAPK1ALDH1A1THRBLGALS1LGALS3 | |
| SCHEMBL13365613 | 0.94 | MAPK1 (0.48) | MAPK1ALDH1A1THRBLGALS1LGALS3 | |
| SCHEMBL10388280 | 0.94 | MAPK1 (0.48) | MAPK1ALDH1A1THRBLGALS1LGALS3 | |
| SCHEMBL16678814 | 0.94 | MAPK1 (0.48) | MAPK1ALDH1A1THRBLGALS1LGALS3 | |
| SCHEMBL21783074 | 0.87 | MAPK1 (0.41) | MAPK1ALDH1A1THRBSLC2A1 | |
| SCHEMBL24758832 | 0.87 | MAPK1 (0.41) | MAPK1ALDH1A1THRBSLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10858698-B2 | Barcoded protein array for multiplex single-molecule interaction profiling | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2020-12-08 | — | — | US | disclosed |
| US-20170107566-A1 | Bardcoded Protein Array for Multiplex Single-Molecule Interaction Profiling | UNITED STATES DEPARTMENT OF ENERGY | 2017-04-20 | — | — | US | disclosed |
| WO-2015148606-A9 | BARCODED PROTEIN ARRAY FOR MULTIPLEX SINGLE-MOLECULE INTERACTION PROFILING | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2016-01-07 | — | — | WO | disclosed |
| WO-2015148606-A2 | BARCODED PROTEIN ARRAY FOR MULTIPLEX SINGLE-MOLECULE INTERACTION PROFILING | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2015-10-01 | — | — | WO | disclosed |
| EP-2580314-A2 | OMV (OUTER MEMBRANE VESICLE) VACCINES | Novartis AG (CH) | 2013-04-17 | — | — | EP | disclosed |
| US-8137932-B2 | Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment | UNIVERSITY OF ZURICH (CH) | 2012-03-20 | — | — | US | disclosed |
| WO-2011161551-A2 | OMV VACCINES | NOVARTIS AG (CH) | 2011-12-29 | — | — | WO | disclosed |
| EP-1718756-B1 | BOTULINUM TOXIN SCREENING ASSAYS | ALLERGAN INC (US) | 2011-11-16 | — | — | EP | disclosed |
| US-20110136173-A1 | Novel Method for the Stabilization of Chimeric Immunoglobulins or Immunoglobulin Fragments, and Stabilized Anti-EGP-2 SCFV Fragment | UNIVERSITY OF ZURICH (DE) | 2011-06-09 | — | — | US | disclosed |
| US-7858088-B2 | Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment | UNIVERSITY OF ZURICH (CH) | 2010-12-28 | — | — | US | disclosed |
| US-7341722-B2 | Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment | UNIVERSITY OF ZURICH (CH) | 2008-03-11 | — | — | US | disclosed |
| US-20080003240-A1 | Botulinum Toxin Screening Assays | ALLERGAN, INC. | 2008-01-03 | — | — | US | disclosed |
| US-20060159683-A1 | Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment | UNIVERSITY OF ZURICH (CH) | 2006-07-20 | — | — | US | disclosed |
| US-7033798-B2 | Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment | UNIVERSITY OF ZURICH (CH) | 2006-04-25 | — | — | US | disclosed |
| US-20020146846-A1 | Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment | ZURICH, UNIVERSITY OF (CH) | 2002-10-10 | — | — | US | disclosed |
| EP-1171468-A2 | METHOD FOR THE STABILIZATION OF CHIMERIC IMMUNOGLOBULINS OR IMMUNOGLOBULIN FRAGMENTS, AND STABILIZED ANTI-EGP-2 SCFV FRAGMENT | Universität Zürich (CH) | 2002-01-16 | — | — | EP | disclosed |
| WO-2000061635-A2 | METHOD FOR THE STABILIZATION OF CHIMERIC IMMUNOGLOBULINS OR IMMUNOGLOBULIN FRAGMENTS, AND STABILIZED ANTI-EGP-2 SCFV FRAGMENT | Universität Zürich (CH) | 2000-10-19 | — | — | WO | disclosed |
| US-5874254-A | ISOLATED AND PURIFIED FIBROBLAST GROWTH FACTOR POLYPEPTIDE ENCODED BY DNA, REGULATING THE RESTORATION OR DEVELOPMENT OF HAIRS ON THE HEAD AND BODY | DIRECTOR-GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1999-02-23 | — | — | US | disclosed |
| EP-0683818-A1 | PROTEIN FUSIONS FOR THE TRANSLOCATION OF APO-PROTEIN INTO THE PERIPLASMIC SPACE | The University of Wales, Aberystwyth (GB) | 1995-11-29 | — | — | EP | disclosed |
| WO-1994017191-A2 | PROTEIN FUSIONS FOR THE TRANSLOCATION OF APO-PROTEINS INTO THE PERIPLASMIC SPACE | UNIVERSITY COLLEGE OF WALES, ABERYSTWYTH (GB) | 1994-08-04 | — | — | WO | disclosed |